GemPharmatech (SH:688046) Xin Lang Cai Jing·2025-10-31 02:55Group 1 - The core viewpoint of the news is that Yaokang Bio has seen a stock price increase of 5.04%, reaching 18.14 CNY per share, with a total market capitalization of 7.437 billion CNY [1] - Yaokang Bio, established on December 29, 2017, specializes in the research, production, and sales of laboratory mouse models, with its main revenue sources being commercial mouse model sales (55.36%), functional efficacy (23.46%), custom breeding (11.32%), model creation (7.06%), and other services (2.70%) [1] Group 2 - Among the top shareholders of Yaokang Bio, the Noan Pioneer Mixed A Fund (320003) reduced its holdings by 265,200 shares in the third quarter, now holding 5.0687 million shares, which is 1.24% of the circulating shares [2] - The Noan Pioneer Mixed A Fund has achieved a year-to-date return of 37.16%, ranking 2306 out of 8154 in its category, and a one-year return of 41.44%, ranking 1675 out of 8046 [2]